Navigation Links
Lactose intolerance linked to ancestral environment

Got milk? Many people couldn't care less because they can't digest it. A new Cornell University study finds that it is primarily people whose ancestors came from places where dairy herds could be raised safely and economically, such as in Europe, who have developed the ability to digest milk.

On the other hand, most adults whose ancestors lived in very hot or very cold climates that couldn't support dairy herding or in places where deadly diseases of cattle were present before 1900, such as in Africa and many parts of Asia, do not have the ability to digest milk after infancy.

"The implication is that harsh climates and dangerous diseases negatively impact dairy herding and geographically restrict the availability of milk, and that humans have physiologically adapted to that," said evolutionary biologist Paul Sherman, a professor of neurobiology and behavior at Cornell. "This is a spectacular case of how cultural evolution -- in this case, the domestication of cattle -- has guided our biological evolution."

Although all mammalian infants drink their mothers' milk, humans are the only mammals that drink milk as adults. But most people -- about 60 percent and primarily those of Asian and African descent -- stop producing lactase, the enzyme required to digest milk, as they mature. People of northern European descent, however, tend to retain the ability to produce the enzyme and drink milk throughout life.

Sherman and former Cornell undergraduate student Gabrielle Bloom '03, now a graduate student at the University of Chicago, compiled data on lactose intolerance (the inability to digest dairy products) from 270 indigenous African and Eurasian populations in 39 countries, from southern Africa to northern Greenland. Their findings will be published in a forthcoming issue of Evolution and Human Behavior.

On average, Sherman and Bloom found that 61 percent of people studied were lactose intolerant, with a range of 2 percent in Denmar
'"/>

Source:Cornell University News Service


Page: 1 2 3

Related biology news :

1. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
2. Low level of extinction during ice age linked to adaptability
3. Improved statistical tools reveal many linked loci
4. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
5. Attacks of King George IIIs madness linked to key metabolism molecule
6. Gene controlling circadian rhythms linked to drug addiction
7. Physical and functional interaction of key cell growth molecules linked to cancer
8. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
9. Naturally occurring asbestos linked to lung cancer
10. Disappearing arctic lakes linked to climate change
11. Genes linked to treatment resistance in children with leukemia

Post Your Comments:
(Date:12/4/2009)...ging accepted thinking about amyloids the fibrous... Alzheimer,s and Parkinson,s and may open up a po...eved that amyloid fibrils - rope-like structures m... inert, but that there may be toxic phases during ...isease. , But in a paper published today [04 De...
(Date:12/3/2009)... BIO-key International, ...ess public safety and finger-based biometric ident...its shareholders at a Special Shareholder Meeting ...Enforcement Division to Interact911 Mobile Systems...r and 1.2% were opposed. ,, (Logo: http://www....
(Date:12/3/2009)...n and his co-workers discovered that specific type...cer. Scientists soon found out how these pathogens... the main culprits are viral proteins E6 and E7. B... functions, thus promoting cell growth. , Profe... now discovered another mechanism by which the E6 ...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Papillomavirus silences innate immune response 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 1Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 3Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5New national study finds increase in P E class related injuries 53440 1New national study finds increase in P E class related injuries 53440 2
... A team of scientists at the Genome Institute of ...n city-state,s Agency for Science, Technology and ...a at San Francisco have developed a pharmacologica... and epigenetic defects in the signaling of a prot...d to be abnormally activated in human malignance, ...
... Using the same concept behind commercial breath... has developed a new, easier method for clinical t...oratory of Gustatory Psychophysics in the Biology ...nology ( http://www.temple.edu/biology ), has crea...ps, but these edible strips contain one of the fiv...
... WESTCHESTER, Ill. Total fat intake and dinner f...attern in healthy adults, according to a research ...P 2008, the 22nd Annual Meeting of the Associated ... authored by Cibele Crispim, of the Federal Univer... volunteers between 20-45 years of age, whose food...
Other Biology News:Taking a cue from breath fresheners, researcher develops new method for taste testing 2Taking a cue from breath fresheners, researcher develops new method for taste testing 3Fat intake negatively influences the sleep pattern in healthy adults 2
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire/ -... Everyone,s Problem and Heritage" , Coinc... 2-3 June 2010 the,Gabonese Republic is hosting an... the issue of safeguarding biological resources in...ment and state leaders, ministers,scientific expe...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 Te...aders in technology development and product integr...nounced the December 11th deadline for technology ... its 14th year, TechConnect World, in association ...TI), and the Clean Technology and Sustainable Indu...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte...el oral JAK2 inhibitor, SB1518, at The American So...tion in New Orleans. ,, Data will be presented ...lation trial of SB1518 detailing its safety, toler...) profile in dose levels ranging from 100 to 600 m...
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ -...Company") (NYSE: SCR ), a leading pharmaceutical...uring, and marketing of branded,generic and propri...at 105 of,its drugs have been included in China,s ...as issued by China,s Ministry of Human Resources a...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...Pills, sponges, IUDs, diaphragms-- women have many...m quite perfect. But what if men want to help out...s usually permanent, and condoms, which are crucia...s. Will men ever have a way to reliably make sure...they are ready? , For decades, pundits have predi...
... Annual Samter Journalism Awards ...pt. 28 The American Academy of Allergy,Asthma & I...l specialty,organization in the United States repr...immunologists, allied health professionals and oth...eatment of allergic disease,is now accepting entri...
...L, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune T...X.V.NTB), is pleased to report its,financial resul...the last,fiscal year, Neptune improved its product...ng its business development strategy to,penetrate ...g in,sustainable sales growth. Financial Results ...
Other Biology Technology:Of mice and men: new male contraceptives successful in rodents and humans 2AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 3
MitoPT-25:MITOCHONDRIAL PERMEABILITY TRANSITION KIT from AbD Serotec
Rabbit Anti-Human DDX5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Human phospho-RTKs Antibody array Assay Kit from R&D Systems
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Biology Products: